Anti-CETP/ BPIFF/ HDLCQ10 functional antibody

Anti-CETP/ BPIFF/ HDLCQ10 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CETP/CETP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T15334-Ab-1/ GM-Tg-hg-T15334-Ab-2Anti-Human CETP monoclonal antibodyHuman
GM-Tg-rg-T15334-Ab-1/ GM-Tg-rg-T15334-Ab-2Anti-Rat CETP monoclonal antibodyRat
GM-Tg-mg-T15334-Ab-1/ GM-Tg-mg-T15334-Ab-2Anti-Mouse CETP monoclonal antibodyMouse
GM-Tg-cynog-T15334-Ab-1/ GM-Tg-cynog-T15334-Ab-2Anti-Cynomolgus/ Rhesus macaque CETP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T15334-Ab-1/ GM-Tg-felg-T15334-Ab-2Anti-Feline CETP monoclonal antibodyFeline
GM-Tg-cang-T15334-Ab-1/ GM-Tg-cang-T15334-Ab-2Anti-Canine CETP monoclonal antibodyCanine
GM-Tg-bovg-T15334-Ab-1/ GM-Tg-bovg-T15334-Ab-2Anti-Bovine CETP monoclonal antibodyBovine
GM-Tg-equg-T15334-Ab-1/ GM-Tg-equg-T15334-Ab-2Anti-Equine CETP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T15334-Ab-1/ GM-Tg-hg-T15334-Ab-2; GM-Tg-rg-T15334-Ab-1/ GM-Tg-rg-T15334-Ab-2;
GM-Tg-mg-T15334-Ab-1/ GM-Tg-mg-T15334-Ab-2; GM-Tg-cynog-T15334-Ab-1/ GM-Tg-cynog-T15334-Ab-2;
GM-Tg-felg-T15334-Ab-1/ GM-Tg-felg-T15334-Ab-2; GM-Tg-cang-T15334-Ab-1/ GM-Tg-cang-T15334-Ab-2;
GM-Tg-bovg-T15334-Ab-1/ GM-Tg-bovg-T15334-Ab-2; GM-Tg-equg-T15334-Ab-1/ GM-Tg-equg-T15334-Ab-2
Products NameAnti-CETP monoclonal antibody
Formatmab
Target NameCETP
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CETP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T15334-Ag-1Recombinant multi-species CETP/ BPIFF/ HDLCQ10 protein
    ORF Viral VectorpGMLP003903human CETP Lentivirus plasmid
    ORF Viral VectorvGMLP003903human CETP Lentivirus particle


    Target information

    Target IDGM-T15334
    Target NameCETP
    Gene ID1071,710267
    Gene Symbol and SynonymsBPIFF,CETP,HDLCQ10
    Uniprot AccessionP11597
    Uniprot Entry NameCETP_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000087237
    Target ClassificationN/A

    The target: CETP, gene name: CETP, also named as BPIFF, HDLCQ10. The protein encoded by this gene is found in plasma, where it is involved in the transfer of cholesteryl ester from high density lipoprotein (HDL) to other lipoproteins. Defects in this gene are a cause of hyperalphalipoproteinemia 1 (HALP1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.